Pharmac looks to fund two new leukaemia treatments
Blood Cancer Chief Executive Tim Edmonds says the treatments would typically cost patients upwards of $150,000 a year.
Blood Cancer Chief Executive Tim Edmonds says the treatments would typically cost patients upwards of $150,000 a year.